Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLEC18B mRNA | CTD | PMID:28628672 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of CLEC18B mRNA | CTD | PMID:32234424 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of CLEC18B mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CLEC18B promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CLEC18B mRNA | CTD | PMID:32234424 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CLEC18B mRNA | CTD | PMID:31163220 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLEC18B mRNA | CTD | PMID:28628672 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CLEC18B mRNA | CTD | PMID:19549813 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLEC18B mRNA | CTD | PMID:28628672 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CLEC18B protein | CTD | PMID:23301498 | ethylparaben | decreases expression | EXP | | 6480464 | ethyl-p-hydroxybenzoate results in decreased expression of CLEC18B mRNA | CTD | PMID:37690743 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CLEC18B mRNA | CTD | PMID:28628672 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CLEC18B mRNA | CTD | PMID:35811015 | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of CLEC18B mRNA | CTD | PMID:26079696 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CLEC18B mRNA | CTD | PMID:35811015 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CLEC18B mRNA | CTD | PMID:34032870 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CLEC18B gene | CTD | PMID:29154799 | |